California Department of Public Health

The decision opens up the largest market in the country to the firm's lymphoma and leukemia testing services.

NEW YORK (GenomeWeb News) – Silicon Valley Biosystems today said that its in silico diagnostics laboratory has received CLIA certification from the California Department of Public Health.

"Most of the benefit of this program has already been had," said a UC Berkeley genetics professor after the California Department of Public Health limited the scope of the university's educational genetic testing project because it determined it was providing medical information.

The California Department of Public Health has said that part of the school's plan to test the DNA of incoming freshmen for three gene variants is not allowed by CLIA law, but the school hopes that lessons will be learned anyway.

BioArray Briefs

Premium

CGC Genetics, Nuvera Biosciences, Veridex, ImaGenes, CapitalBio, Fisher Healthcare, Osmetech, National Institutes of Health, Clinical Data, Cogenics, UK Biotechnology and Biological Sciences Research Council

Navigenics’ lower-priced program to incorporate genetic risk data in patients’ annual medical checkup raises questions as to whether personal genomics firms should be broadly marketing their services to physicians.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.